Juul Labs shares new research at the College on Problems of Drug Dependence Annual Meeting

June 23, 2020

San Francisco (June 22, 2020) -- As part of the Company's ongoing engagement with the public health community, Juul Labs today announced findings from its sciences and research program at the 82nd Annual Scientific Meeting of the College on Problems of Drug Dependence. The studies presented evaluate the pharmacokinetic and pharmacodynamic profile of the JUUL System compared to other nicotine delivery products.

Consistent with previous clinical studies conducted by Juul Labs, the data demonstrated a nicotine absorption curve for the JUUL System that is competitive with a combustible cigarette but with a lower maximum blood nicotine concentration and total nicotine exposure compared to combustible cigarettes. The JUUL System's nicotine absorption curve was in close range of select comparator ENDS and a heated tobacco product.

Below are the Juul-sponsored studies that were shared at the conference:"When considering laws and regulations governing nicotine, policymakers should bear in mind: Providing a similar nicotine effect and experience to combustible cigarettes is critical to facilitate an adult smoker's transition away from smoking," said Mark Rubinstein, Vice President of Global Scientific Affairs at Juul Labs.

The Company will continue to share results from its science and research program with the public health communities as it works to support the scientific basis for the category, as well as future regulatory filings.
-end-
About Juul Labs

JUUL Labs' mission is to transition the world's billion adult smokers away from combustible cigarettes, eliminate their use, and combat underage usage of our products. We believe that vapor products can offer adult smokers an alternative to combustible cigarettes and, in so doing, reduce the harm associated with tobacco. Nicotine is addictive and can cause certain harms to health. It would be best if no one used any nicotine product. Anyone who smokes should quit. Adult smokers who have not successfully quit should completely switch to potentially less harmful alternative nicotine products. JUUL Labs does not want any non-nicotine users, especially those underage, to try our products, as they exist only to transition adult smokers away from combustible cigarettes.

For more information about the company, please visit http://www.juullabs.com.

Juul Labs

Related Drug Dependence Articles from Brightsurf:

Juul Labs shares new research at the College on Problems of Drug Dependence Annual Meeting
As part of the Company's ongoing engagement with the public health community, Juul Labs today announced findings from its sciences and research program at the 82nd Annual Scientific Meeting of the College on Problems of Drug Dependence.

Exploring mass dependence in electron-hole clusters
A study published in EPJ B reveals that the behaviour of one type of three-particle cluster displays a distinct relationship with the ratio between the masses of its particles.

A history of cannabis dependence associated with many negative mental health outcomes
More than 1% of Canadians have been dependent on cannabis at some point in their lives.

Researchers say extended antidepressant use creates physical dependence
Researchers explain symptoms associated with Antidepressant Discontinuation Syndrome and provide a schedule for tapering various classes of antidepressants.

Opioid dependence found to permanently change brains of rats
Approximately one-quarter of patients who are prescribed opioids for chronic pain misuse them, with five to 10 percent developing an opioid use disorder or addiction.

Tweets indicate nicotine dependence, withdrawal symptoms of JUUL users
As e-cigarette brand JUUL continues to climb in popularity among users of all ages, University of Pittsburgh School of Medicine researchers took a unique approach to analyzing its impact by using Twitter to investigate any mention of nicotine effects, symptoms of dependence and withdrawal in regards to JUUL use.

Potential novel biomarker for alcohol dependence
Specific molecules (small noncoding microRNAs or miRNAs) found in saliva may be able to predict alcohol dependence as biomarkers.

Alcohol dependence, psychiatric disorders share genetic links
An international team of researchers has identified a gene that regulates how quickly the body metabolizes alcohol as a key risk factor for alcohol dependence.

Serotonin-Noradrenalin reuptake inhibitors may cause dependence and withdrawal when stopped
The difficulties that people have in discontinuing antidepressant medications has been in the news recently.

Wide variation across the nation in treatment for opioid abuse and dependence
Whether treatment for opioid abuse and dependence most commonly emphasized methadone administration, naltrexone injection, group psychotherapy or another procedure in 2017 depended on the state or region where the patient received care, according to a new white paper and state-by-state infographics from FAIR Health.

Read More: Drug Dependence News and Drug Dependence Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.